Results 131 to 140 of about 355,625 (242)

Estimating the transmission parameters of pneumococcal carriage in households [PDF]

open access: yes, 2004
This paper analyses Streptococcus pneumoniae transmission dynamics in households using longitudinal data on pneumococcal (Pnc) carriage in the United Kingdom. Ten consecutive swabs were taken at 4-week intervals from all members of 121 households.
Gay, N. J.   +2 more
core   +2 more sources

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain

open access: yesPLoS ONE, 2017
A prospective laboratory-based multicenter study that collected all adult invasive pneumococcal disease (IPD) episodes from 6 Spanish hospitals before (2008–2009) and after (2012–2013).
J. Càmara   +10 more
semanticscholar   +1 more source

Epidemic of Invasive Pneumococcal Disease, Western Canada, 2005–2009

open access: yesEmerging Infectious Diseases, 2012
In Canada before 2005, large outbreaks of pneumococcal disease, including invasive pneumococcal disease caused by serotype 5, were rare. Since then, an epidemic of serotype 5 invasive pneumococcal disease was reported: 52 cases during 2005, 393 during ...
Gregory J. Tyrrell   +11 more
doaj   +1 more source

Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution

open access: yesBMC Infectious Diseases, 2017
BackgroundIn Japan, the clinical characteristics and recent serotype distribution among adult patients of invasive pneumococcal disease (IPD) have not been fully investigated since the introduction of the pneumococcal conjugate vaccine (PCV) in children.
Munehisa Fukusumi   +14 more
semanticscholar   +1 more source

The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis [PDF]

open access: yes, 2001
Objectives Burden of pneumococcal disease depends on the prevalence and invasive disease potential of serotypes. We aimed to estimate the invasive disease potential of serotypes in children under 5 years of age by combining data from different settings ...
Balsells, E   +28 more
core   +3 more sources

Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012–2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes

open access: yesFrontiers in Microbiology, 2016
Since 2010 the 13-valent pneumococcal conjugate vaccine (PCV13) replaced the 7-valent vaccine (PCV7) as the leading pneumococcal vaccine used in children through the private sector. Although, neither of the PCVs were used significantly in adults, changes
Andreia N. Horácio   +5 more
semanticscholar   +1 more source

A New Perspective on Determining Disease Invasion and Population Persistence in Heterogeneous Environments [PDF]

open access: yesarXiv
We introduce a new quantity known as the network heterogeneity index, denoted by $\mathcal{H}$, which facilitates the investigation of disease propagation and population persistence in heterogeneous environments. Our mathematical analysis reveals that this index embodies the structure of such networks, the disease or population dynamics of patches, and
arxiv  

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects

open access: yesGlobal Journal of Medicine and Public Health
Pneumococcus is an important cause of community acquired pneumonia and the commonest cause of community acquired bacterial pneumonia. It also causes invasive pneumococcal disease that increases hospitalization rates, economic burden, morbidity and ...
Salil Bendre   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy